Marksans Pharma Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 43.87% of Marksans Pharma, FIIs hold 19.06%, DIIs hold 5.54% and the public holds 31.53%. Promoter holding was unchanged from Jun 2026.
Get an alert when Marksans Pharma reports results or its shareholding changes. Free account.
Promoters
43.87%
unchanged QoQ
FIIs
19.06%
+1.59 pp QoQ
DIIs
5.54%
−0.65 pp QoQ
Public
31.53%
−0.93 pp QoQ
Marksans Pharma shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 43.87% | 19.06% | 5.54% | 31.53% | 2,47,508 |
| Jun 2026 | 43.87% | 17.47% | 6.19% | 32.46% | 2,46,635 |
| Mar 2026 | 43.87% | 16.76% | 6.57% | 32.78% | 2,46,279 |
| Dec 2025 | 43.87% | 8.13% | 5.91% | 42.08% | 2,55,153 |
| Sep 2025 | 43.87% | 16.92% | 5.28% | 33.93% | 2,65,788 |
| Jun 2025 | 43.87% | 19.89% | 5.50% | 30.74% | 2,56,221 |
| Mar 2025 | 43.87% | 22.19% | 4.55% | 29.37% | 2,57,273 |
| Dec 2024 | 43.87% | 21.95% | 4.30% | 29.88% | 2,59,813 |
| Sep 2024 | 43.87% | 21.31% | 4.10% | 30.70% | 2,48,845 |
| Jun 2024 | 43.87% | 18.59% | 3.75% | 33.77% | 2,35,500 |
| Mar 2024 | 43.85% | 15.57% | 5.17% | 35.40% | 2,54,699 |
| Dec 2023 | 43.85% | 15.55% | 4.76% | 35.81% | 2,37,377 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹14.43k cr, the promoter group's 43.87% stake is worth ₹6.33k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Marksans Pharma shareholding: common questions
What is the promoter holding in Marksans Pharma?
Promoters hold 43.87% of Marksans Pharma as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Marksans Pharma?
Foreign institutional investors (FIIs) held 19.06% of Marksans Pharma in Sep 2026, +1.59 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Marksans Pharma?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 5.54% of Marksans Pharma in Sep 2026, −0.65 pp versus Jun 2026.
Is the promoter holding in Marksans Pharma pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Marksans Pharma.
How has Marksans Pharma's promoter holding changed in the last year?
Promoter holding moved from 43.87% in Sep 2025 to 43.87% in Sep 2026 (unchanged).
How many shareholders does Marksans Pharma have?
Marksans Pharma had 2,47,508 shareholders in Sep 2026, compared with 2,46,635 in Jun 2026.